Cohance Lifesciences Market Cap

Cohance Lifesciences has a market cap or net worth of 377.23 billion as of August 14, 2025. Its market cap has increased by 65.24% in one year.

Market Cap

377.23B

Enterprise Value

378.66B

Revenue

11.98B

Ranking

n/a

PE Ratio

94.36

Stock Price

910.00

Market Cap Chart

Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 377.23B, an increase of 1,119,111.77%. That is a compound annual growth rate of 456.24%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	377.23B	30.13%
Dec 31, 2024	289.89B	57.55%
Dec 29, 2023	184.00B	46.05%
Dec 30, 2022	125.98B	0.33%
Dec 31, 2021	125.56B	9.05%
Dec 31, 2020	115.14B	341,510.23%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,859.09B
Divi's Laboratories	1,590.69B
Cipla	1,200.16B
Apollo Hospitals Enterprise	1,043.73B
Mankind Pharma	1,006.03B
Zydus Lifesciences	941.99B
Fortis Healthcare	695.05B
Aurobindo Pharma	611.53B

Market Cap Rankings